Updated data from the BEXMAB study reveals a significant increase in complete remission rates for patients with high-risk ...

At Akron’s Children’s Hospital, Negan was diagnosed with Acute Myeloid Leukemia (AML). According to the American Cancer ...

Proceeding with hematopoietic stem cell transplantation (HSCT) is more cost-effective than delaying the procedure in patients ...

Scientists studying a hard-to-treat form of blood cancer called acute myeloid leukemia (AML) have found that a type of treatment—immunotherapy—may help change the environment where cancer cells live, ...

An 11-year-old girl from Palm City has just begun the fight of her life. Layla Morales was recently diagnosed with acute ...

Peter Mac researchers have discovered a powerful new drug combination that could offer hope to children and adults with certain subtypes of acute myeloid leukemia (AML).

MUSC researchers at the Hollings Cancer center are making strides in new developments for leukemia treatment.Sophie Paczesny, M.D., Ph.D., the principal investi ...

SELLAS Life Sciences reports successful Phase 2 trial results for SLS009 in relapsed/refractory AML, exceeding response and survival rates.

Scientists studying a hard-to-treat form of blood cancer called acute myeloid leukemia (AML) have found that a type of treatment — immunotherapy — may help change the environment where cancer cells ...